These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 26813972)

  • 1. Type 2 Diabetes Mellitus in Saudi Arabia: Major Challenges and Possible Solutions.
    Robert AA; Al Dawish MA; Braham R; Musallam MA; Al Hayek AA; Al Kahtany NH
    Curr Diabetes Rev; 2017; 13(1):59-64. PubMed ID: 26813972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature.
    Al Dawish MA; Robert AA; Braham R; Al Hayek AA; Al Saeed A; Ahmed RA; Al Sabaan FS
    Curr Diabetes Rev; 2016; 12(4):359-368. PubMed ID: 26206092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Status of Knowledge and Awareness of Diabetes Mellitus in Saudi Arabia.
    Robert AA; Al Awad AD; Al Dawish MA
    Curr Diabetes Rev; 2021; 17(5):e101220186818. PubMed ID: 33045977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Saudi Abnormal Glucose Metabolism and Diabetes Impact Study (SAUDI-DM).
    Al-Rubeaan K; Al-Manaa H; Khoja T; Ahmad N; Al-Sharqawi A; Siddiqui K; AlNaqeb D; Aburisheh K; Youssef A; Al-Batil A; Al-Otaibi M; Ghamdi AA
    Ann Saudi Med; 2014; 34(6):465-75. PubMed ID: 25971818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of digital health using the transtheoretical model to prevent or delay type 2 diabetes in impaired glucose tolerance patients: protocol for a randomized control trial.
    Alzeidan R; Shata Z; Hassounah MM; Baghdadi LR; Hersi A; Fayed A; Kashour T; Elmorshedy H
    BMC Public Health; 2019 Nov; 19(1):1550. PubMed ID: 31752774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Disease among Patients with Diabetes: The Current Scenario in Saudi Arabia.
    Robert AA; Al Dawish MA
    Curr Diabetes Rev; 2021; 17(2):180-185. PubMed ID: 32459609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care services provided to type 1 and type 2 diabetic patients in Saudi Arabia.
    Al-Rubeaan KA; Al-Manaa HA; Khoja TA; Al-Sharqawi AH; Aburisheh KH; Youssef AM; Alotaibi MS; Al-Gamdi AA
    Saudi Med J; 2015 Oct; 36(10):1216-25. PubMed ID: 26446334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular complications among patients with diabetes: An emerging health problem in Saudi Arabia.
    Alwin Robert A; Al Dawish MA
    Diab Vasc Dis Res; 2019 May; 16(3):227-235. PubMed ID: 30599757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultural adaptation of self-management of type 2 diabetes in Saudi Arabia (qualitative study).
    Al Slamah T; Nicholl BI; Alslail FY; Harris L; Melville CA; Kinnear D
    PLoS One; 2020; 15(7):e0232904. PubMed ID: 32722666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle factors and macro- and micro-vascular complications among people with type 2 diabetes in Saudi Arabia.
    Alramadan MJ; Magliano DJ; Alhamrani HA; Alramadan AJ; Alameer SM; Amin GM; Alkharras WA; Bayaseh NA; Billah B
    Diabetes Metab Syndr; 2019; 13(1):484-491. PubMed ID: 30641750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes.
    Gupta V; Baabbad R; Hammerby E; Nikolajsen A; Shafie AA
    J Med Econ; 2015 Apr; 18(4):263-72. PubMed ID: 25426701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes complications in 1952 type 2 diabetes mellitus patients managed in a single institution in Saudi Arabia.
    Alwakeel JS; Sulimani R; Al-Asaad H; Al-Harbi A; Tarif N; Al-Suwaida A; Al-Mohaya S; Isnani AC; Alam A; Hammad D
    Ann Saudi Med; 2008; 28(4):260-6. PubMed ID: 18596402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Obesity in Saudi Arabia: Healthcare Resource Use and Costs Associated with Obesity-Related Complications.
    Al-Omar HA; Alshehri A; Abanumay A; Alabdulkarim H; Alrumaih A; Eldin MS; Alqahtani SA
    Adv Ther; 2023 Apr; 40(4):1430-1443. PubMed ID: 36680731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle related risk factors of type 2 diabetes mellitus in Saudi Arabia.
    Midhet FM; Al-Mohaimeed AA; Sharaf FK
    Saudi Med J; 2010 Jul; 31(7):768-74. PubMed ID: 20635010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Worrying Trend of Diabetes Mellitus in Saudi Arabia: An Urgent Call to Action.
    Robert AA; Al Dawish MA
    Curr Diabetes Rev; 2020; 16(3):204-210. PubMed ID: 31146665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus in Saudi Arabia.
    Al-Nozha MM; Al-Maatouq MA; Al-Mazrou YY; Al-Harthi SS; Arafah MR; Khalil MZ; Khan NB; Al-Khadra A; Al-Marzouki K; Nouh MS; Abdullah M; Attas O; Al-Shahid MS; Al-Mobeireek A
    Saudi Med J; 2004 Nov; 25(11):1603-10. PubMed ID: 15573186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and future prediction of type 2 diabetes mellitus in the Kingdom of Saudi Arabia: A systematic review of published studies.
    Meo SA
    J Pak Med Assoc; 2016 Jun; 66(6):722-5. PubMed ID: 27339576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and prevalence rates of diabetes mellitus in Saudi Arabia: An overview.
    Alotaibi A; Perry L; Gholizadeh L; Al-Ganmi A
    J Epidemiol Glob Health; 2017 Dec; 7(4):211-218. PubMed ID: 29110860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct medical cost and glycemic control in type 2 diabetic Saudi patients.
    Almutairi N; Alkharfy KM
    Appl Health Econ Health Policy; 2013 Dec; 11(6):671-5. PubMed ID: 24174262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prevalence and Risk Factors of Type 2 Diabetes Mellitus (DMT2) in a Semi-Urban Saudi Population.
    Al Mansour MA
    Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31861311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.